MIRA Stock Analysis: Buy, Sell, or Hold?
MIRA - MIRA Pharmaceuticals, Inc. Common Stock
$1.01
-0.03 (-2.88%)
▼
5d:
-12.55%
30d:
-1.94%
90d:
-17.21%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When MIRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MIRA is down 12.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MIRA is down 12.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MIRA is currently trading at $1.01, which is considered fair relative to its 30-day fair value range of $0.97 to $1.06.
Technical Outlook: Technically, MIRA is in a strong downtrend. Immediate support is located at $0.95, while resistance sits at $1.20.
Market Sentiment: MIRA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.75 (+1657.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MIRA is in a strong downtrend. Immediate support is located at $0.95, while resistance sits at $1.20.
Market Sentiment: MIRA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.75 (+1657.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.97 -
$1.06
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1657.4% below Wall St target ($17.75)
- WARNING: Recommendation downgraded due to -12.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.97 -
$1.06
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.95
Resistance Level
$1.20
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.46
Wall Street Target
$17.75
(+1657.4%)
Share & Embed Analysis
Last updated: June 03, 2026 7:58 PM ET
Data refreshes hourly during market hours. Next update: 8:58 PM
Data refreshes hourly during market hours. Next update: 8:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MIRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1211 | 59 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 57 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$253 | 66 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$352 | 65 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$219 | 55 HOLD |
